Patrick Roth Selected Research

Patrick Roth Research Topics

Disease

67	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 04/2006
64	Neoplasms (Cancer) 04/2024 - 11/2009
44	Glioma (Gliomas) 11/2023 - 04/2006
14	Brain Neoplasms (Brain Tumor) 01/2023 - 12/2010
12	Lymphoma (Lymphomas) 01/2023 - 05/2010
6	Seizures (Absence Seizure) 01/2024 - 04/2014
5	Epilepsy (Aura) 01/2024 - 04/2014
4	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2013
3	Astrocytoma (Pilocytic Astrocytoma) 01/2024 - 08/2021
3	Virus Diseases (Viral Diseases) 02/2023 - 10/2017
3	Ependymoma 08/2021 - 04/2016
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 10/2020
2	Infections 09/2023 - 10/2017
2	Residual Neoplasm 01/2023 - 01/2018
2	Necrosis 01/2023 - 10/2020
2	Disease Progression 01/2023 - 01/2020
2	Meningioma (Meningiomas) 01/2023 - 01/2017
2	Multiple Myeloma 10/2020 - 07/2015
2	Inflammation (Inflammations) 09/2019 - 02/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2015 - 01/2014
2	Edema (Dropsy) 11/2013 - 12/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023

Drug/Important Bio-Agent (IBA)

22	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 03/2009
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2006
13	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024 - 12/2011
10	Messenger RNA (mRNA)IBA 11/2022 - 04/2006
8	MethyltransferasesIBA 01/2024 - 04/2014
8	Bevacizumab (Avastin)FDA Link 11/2022 - 10/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 04/2014
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2011
7	AntigensIBA 11/2023 - 01/2012
7	CytokinesIBA 01/2023 - 04/2014
7	LigandsIBA 12/2019 - 11/2009
6	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2018
6	InterferonsIBA 01/2022 - 09/2012
6	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 02/2013
5	SteroidsIBA 01/2024 - 12/2010
5	Alkylating AgentsIBA 12/2023 - 04/2014
5	MicroRNAs (MicroRNA)IBA 12/2016 - 08/2011
5	IntegrinsIBA 07/2016 - 02/2013
4	O-(6)-methylguanineIBA 01/2024 - 04/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 11/2009
4	Immune Checkpoint InhibitorsIBA 01/2022 - 06/2017
3	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2024 - 11/2009
3	NivolumabIBA 01/2023 - 01/2017
3	Lomustine (CCNU)FDA Link 01/2023 - 12/2013
3	Peptides (Polypeptides)IBA 12/2022 - 02/2013
3	EpitopesIBA 10/2020 - 01/2018
3	CilengitideIBA 03/2016 - 02/2013
3	Anticonvulsants (Antiepileptic Drugs)IBA 03/2016 - 04/2014
3	CaspasesIBA 04/2014 - 11/2009
2	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 04/2024 - 12/2023
2	SteamIBA 04/2024 - 12/2023
2	marizomibIBA 03/2024 - 10/2020
2	Interferon Type IIBA 02/2023 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2014
2	VaccinesIBA 12/2022 - 06/2017
2	vinyltriethoxysilane (VTES)IBA 01/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2022 - 10/2017
2	Phosphotransferases (Kinase)IBA 01/2022 - 11/2019
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 11/2015
2	Antisense OligonucleotidesIBA 12/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2019 - 10/2014
2	Liposomes (Liposome)IBA 10/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 10/2017 - 08/2010
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 07/2015
2	Protein Isoforms (Isoforms)IBA 01/2017 - 11/2013
2	Levetiracetam (Keppra)FDA LinkGeneric 03/2016 - 04/2014
2	Growth Differentiation Factor 15IBA 02/2016 - 08/2010
2	ImmunosorbentsIBA 01/2016 - 08/2010
2	EnzymesIBA 01/2016 - 08/2010
2	Angiogenesis InhibitorsIBA 11/2015 - 02/2013
2	Monoclonal AntibodiesIBA 07/2015 - 11/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2015 - 12/2010
2	Fas Ligand Protein (Fas Ligand)IBA 02/2011 - 11/2009
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2024
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	Memantine (Namenda)FDA Link 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2023
1	Anti-Infective Agents (Microbicides)IBA 09/2023
1	ManganeseIBA 09/2023
1	PlatinumIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	lisavanbulinIBA 01/2023
1	tepotinibIBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2023
1	tisagenlecleucelIBA 01/2023

Therapy/Procedure

35	Therapeutics 04/2024 - 03/2009
28	Drug Therapy (Chemotherapy) 03/2024 - 03/2009
26	Radiotherapy 03/2024 - 12/2012
13	Immunotherapy 01/2023 - 08/2010
10	Chemoradiotherapy 03/2024 - 11/2015
2	Aftercare (After-Treatment) 10/2022 - 01/2019
1	Combined Modality Therapy 02/2023